15:27:26 Europe / Stockholm

Bifogade filer

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Kalender

2024-08-30 Bokslutskommuniké 2024
2024-04-19 Kvartalsrapport 2024-Q3
2024-04-12 Extra Bolagsstämma 2024
2024-02-09 Kvartalsrapport 2024-Q2
2023-10-27 Kvartalsrapport 2024-Q1
2023-09-25 X-dag ordinarie utdelning VSD B 0.00 SEK
2023-09-22 Årsstämma 2024
2023-08-31 Bokslutskommuniké 2023
2023-05-04 Kvartalsrapport 2023-Q3
2023-02-09 Kvartalsrapport 2023-Q2
2022-10-27 Kvartalsrapport 2023-Q1
2022-10-07 X-dag ordinarie utdelning VSD B 0.00 SEK
2022-10-06 Årsstämma 2023
2022-08-30 Bokslutskommuniké 2022
2022-07-05 Extra Bolagsstämma 2022
2022-05-04 Kvartalsrapport 2022-Q3
2022-02-11 Kvartalsrapport 2022-Q2
2021-10-22 Kvartalsrapport 2022-Q1
2021-10-06 X-dag ordinarie utdelning VSD B 0.00 SEK
2021-10-05 Årsstämma 2022
2021-08-30 Bokslutskommuniké 2021
2021-05-12 Kvartalsrapport 2021-Q3
2021-02-12 Kvartalsrapport 2021-Q2
2020-11-12 Kvartalsrapport 2021-Q1
2020-10-08 X-dag ordinarie utdelning VSD B 0.00 SEK
2020-10-07 Årsstämma 2021
2020-08-31 Bokslutskommuniké 2020
2020-05-15 Kvartalsrapport 2020-Q3
2020-05-04 Extra Bolagsstämma 2020
2020-02-14 Kvartalsrapport 2020-Q2
2019-11-01 Kvartalsrapport 2020-Q1
2019-10-10 X-dag ordinarie utdelning VSD B 0.00 SEK
2019-10-09 Årsstämma 2020
2019-08-30 Bokslutskommuniké 2019
2019-05-16 Kvartalsrapport 2019-Q3
2019-02-14 Kvartalsrapport 2019-Q2
2018-10-30 Kvartalsrapport 2019-Q1
2018-10-17 X-dag ordinarie utdelning VSD B 0.00 SEK
2018-10-16 Årsstämma 2019
2018-08-31 Bokslutskommuniké 2018
2018-05-16 Kvartalsrapport 2018-Q3
2018-02-14 Kvartalsrapport 2018-Q2
2017-10-30 Kvartalsrapport 2018-Q1
2017-10-02 X-dag ordinarie utdelning VSD B 0.00 SEK
2017-09-29 Årsstämma 2018
2017-08-30 Bokslutskommuniké 2017
2017-05-22 Kvartalsrapport 2017-Q3
2017-02-20 Kvartalsrapport 2017-Q2
2017-01-25 Extra Bolagsstämma 2017
2016-11-07 Kvartalsrapport 2017-Q1
2016-08-29 X-dag ordinarie utdelning VSD B 0.00 SEK
2016-08-26 Bokslutskommuniké 2016
2016-05-26 Kvartalsrapport 2016-Q3
2016-02-25 Kvartalsrapport 2016-Q2
2015-11-26 Kvartalsrapport 2016-Q1
2015-08-27 Bokslutskommuniké 2015

Beskrivning

LandSverige
ListaSpotlight
SektorHälsovård
IndustriMedicinteknik
Vibrosense Dynamics är verksamt inom medicinteknik. Bolaget utvecklar produkter och tjänster för diagnostikstöd vid nervskador i händer och fötter. Produkterna mäter och kvantifierar förmågan att känna vibrationer i huden, och används av vårdgivare för att kunna anpassa behandlingen eller sätta in förebyggande åtgärder vid potentiella nervskador. Bolagets kunder består huvudsakligen av diabetesmottagningar, sjukhus, vårdcentraler och forskningsinstitut.
2022-12-01 12:00:00

VibroSense Dynamics' (VibroSense) increased activities in Germany and the Nordics have been well received by the market. In Germany, VibroSense has identified a new strategy with existing reimbursement codes that is deemed to significantly facilitate the company's expansion in Germany. VibroSense has received positive response from its marketing activities towards both customers and investors.

VibroSense current main focus is on two business areas, Diabetes and Occupational Health Care. In Germany, where the focus is on Diabetic Foot Screening, this has resulted in collaboration with a reputable consulting company that has helped VibroSense to define a clear strategy for expansion in Germany. This includes support for reimbursement codes, which means that 12% of the German market for health care have the opportunity to get a high subsidy when purchasing or renting the VibroSense Meter ® II.

In Sweden, the Company continues its activities within the Occupational Health Care segment, with continuous training and valued customer support through VibroSense digital platform for training and seminars. The development of the Diabetes business area in Sweden, continues according to plan with the clinics that use and evaluate the Diabetic Foot Screening application. VibroSense has also delivered its first order from Finland, to the university hospital in Kempele.

As part of strengthening the marketing of VibroSense to investors, an updated company presentation has been produced which is available at the following link Home At VibroSense (https://youtu.be/_Wv0cgF6s7U)

"The positive reactions we receive from the market confirm that we have taken a new important step forward both in Germany and in Sweden. Our first delivery to Finland is a new milestone that opens up further opportunities for VibroSense. As we reach new customer groups and move into new segments of the market, it is important for us to show an updated image of our company both to customers and investors," says VibroSense CEO, Hans Wallin.
 

Contact
Hans Wallin, CEO of VibroSense Dynamics AB
Phone: +46 40 88 026
Email: info@vibrosense.com
www.vibrosense.se

"The new Gold Standard for reliable
detection of nerve damage"

About VibroSense Dynamics AB ( publ )
VibroSense Dynamics AB (publ) develops and sells medical technology products and services for diagnostic support for nerve damage in the hands and feet. The method involves measuring and quantifying the ability to feel vibrations at several frequencies. The company's customers are diabetes clinics, occupational health care, hospitals, health centers and researchers.

Our vision is that the company's products should be a standard instrument in all neurological examinations to detect early signs of changes in sensation so that patients and their caregivers can implement preventive measures that prevent, reduce or delay the onset of nerve damage in the hands and feet.